(Q34489386)

2 August 2017

title

Cooperative, nanoparticle-enabled thermal therapy of breast cancer (English)

1 reference

2 August 2017

0 references

1 reference

Haifa Shen

1

1 reference

2 August 2017

Jian You

2

1 reference

2 August 2017

Guodong Zhang

3

1 reference

2 August 2017

Arturas Ziemys

4

1 reference

2 August 2017

Qingpo Li

5

1 reference

2 August 2017

Litao Bai

6

1 reference

2 August 2017

Xiaoyong Deng

7

1 reference

2 August 2017

Donald R Erm

8

1 reference

2 August 2017

Xuewu Liu

9

1 reference

2 August 2017

Chun Li

10

1 reference

2 August 2017

Mauro Ferrari

11

1 reference

2 August 2017

publication date

29 November 2011

1 reference

Advanced Healthcare Materials

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

84-89

1 reference

A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

6 July 2018

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Sustained small interfering RNA delivery by mesoporous silicon particles

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Tuning payload delivery in tumour cylindroids using gold nanoparticles

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Frontiers in cancer nanomedicine: directing mass transport through biological barriers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Near-infrared narrow-band imaging of gold/silica nanoshells in tumors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Mediating tumor targeting efficiency of nanoparticles through design

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Feasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine model

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Experimental and theoretical studies of light-to-heat conversion and collective heating effects in metal nanoparticle solutions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Microscale Heat Transfer Transduced by Surface Plasmon Resonant Gold Nanoparticles

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

An integrated genomic analysis of human glioblastoma multiforme

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

The genomic landscapes of human breast and colorectal cancers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Cancer nanotechnology: opportunities and challenges

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Local detection of electromagnetic energy transport below the diffraction limit in metal nanoparticle plasmon waveguides

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842222

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

6 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201100005

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201100005

Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201100005

Design maps for nanoparticles targeting the diseased microvasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201100005

Size and shape effects in the biodistribution of intravascularly injected particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201100005

Vectoring siRNA therapeutics into the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201100005

Long range surface plasmon and hydrogel optical waveguide field-enhanced fluorescence biosensor with 3D hydrogel binding matrix: on the role of diffusion mass transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201100005

Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23184690

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Width of cluster plasmon resonances: Bulk dielectric functions and chemical interface damping

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23184690

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23184690

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/ADHM.201100005

1 reference

2 August 2017

1 reference

2 August 2017

1 reference